EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunomodulatory Functions of Adipose Mesenchymal Stromal/Stem Cell Derived From Donors With Type 2 Diabetes and Obesity on CD4 T Cells

Marwa Mahmoud iD, Miia Juntunen, Amna Adnan, Laura Kummola, Ilkka S Junttila, Minna Kelloniemi, Tuula Tyrväinen, Heini Huhtala, Abeer I Abd El Fattah, Khalda Amr, Alaa Mohamad El Erian, Mimmi Patrikoski und 1 weitere

Stem Cells · 15.05.2023 · 41 (5) · 505-519

DOI: 10.1093/stmcls/sxad021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells, online erschienen am 22.03.2023. Verfasst von Marwa Mahmoud und 12 weiteren Autor:innen. Beteiligte Einrichtung: Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Mesenchymal Stem Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Finnish National Agency for Education, Tampere University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For adipose stromal/stem cell (ASCs)-based immunomodulatory therapies, it is important to study how donor characteristics, such as obesity and type 2 diabetes (T2D), influence ASCs efficacy. Here, ASCs were obtained from 2 groups, donors with T2D and obesity (dASCs) or nondiabetic donors with normal-weight (ndASCs), and then cultured with anti-CD3/CD28-stimulated allogeneic CD4 T cells. ASCs were studied for the expression of the immunomodulators CD54, CD274, and indoleamine 2, 3 dioxygenase 1 (IDO) in inflammatory conditions. CD4 T cells cultured alone or in cocultures were assessed to evaluate proliferation, activation marker surface expression, apoptosis, the regulatory T cells (Tregs; CD4+ CD25high FOXP3+) frequency, and intracellular cytokine expression using flow cytometry. Modulation of T-cell subset cytokines was explored via ELISA. In inflammatory conditions, the expression of CD54, CD274, and IDO was significantly upregulated in ASCs, with no significant differences between ndASCs and dASCs. dASCs retained the potential to significantly suppress CD4 T-cell proliferation, with a slightly weaker inhibitory effect than ndASCs, which was associated with significantly reduced abilities to decrease IL-2 production and increase IL-8 levels in cocultures. Such attenuated potentials were significantly correlated with increasing body mass index. dASCs and ndASCs comparably reduced CD4 T-cell viability, HLA-DR expression, and interferon-gamma production and conversely increased CD69 expression, the Tregs percentage, and IL-17A production. Considerable amounts of the immunomodulators prostaglandin E2 (PGE2) and IL-6 were detected in the conditioned medium of cocultures. These findings suggest that ASCs obtained from donors with T2D and obesity are receptive to the inflammatory environment and able to modulate CD4 T cells accordingly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Mesenchymal Stem CellsHumansAdipose TissueCD4-Positive T-LymphocytesCytokinesImmunomodulationObesityCell Proliferation

Stichwörter der Autor:innen

CD4 T celladipose mesenchymal stromal/stem cellcytokinesimmunomodulatoryobesitytype 2 diabetes

Substanzen

Cytokines

Autor:innen und Institutionen

  • Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Stem Cell Research Group, Medical Research Centre of Excellence, National Research Centre, Cairo, Egypt.
  • Department of Medical Molecular Genetics, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt.
  • Research, Development, and Innovation Centre, Tampere University Hospital, Tampere, Finland.
  • Biodiversity Interventions for Well-being, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Cytokine Biology Research Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

ORCID-Profile: Marwa Mahmoud

Förderung

  • Academy of Finland
  • Finnish National Agency for Education
  • Tampere University Hospital
  • Fimlab Laboratories
  • Tampere University Hospital Support Foundation
  • Tampere Tuberculosis Foundation
  • Nordlab Laboratories
  • Finnish Cultural Foundation

Zitieren

APA

Mahmoud, M., Juntunen, M., Adnan, A., Kummola, L., Junttila, I. S., Kelloniemi, M., Tyrväinen, T., Huhtala, H., Abd El Fattah, A. I., Amr, K., El Erian, A. M., Patrikoski, M., & Miettinen, S. (2023). Immunomodulatory Functions of Adipose Mesenchymal Stromal/Stem Cell Derived From Donors With Type 2 Diabetes and Obesity on CD4 T Cells. Stem Cells, 41(5), 505-519. https://doi.org/10.1093/stmcls/sxad021

Vancouver

Mahmoud M, Juntunen M, Adnan A, Kummola L, Junttila IS, Kelloniemi M, et al. Immunomodulatory Functions of Adipose Mesenchymal Stromal/Stem Cell Derived From Donors With Type 2 Diabetes and Obesity on CD4 T Cells. Stem Cells. 2023;41(5):505-519. doi:10.1093/stmcls/sxad021

BibTeX
@article{Mahmoud2023,
  author = {Mahmoud, Marwa and Juntunen, Miia and Adnan, Amna and Kummola, Laura and Junttila, Ilkka S and Kelloniemi, Minna and Tyrväinen, Tuula and Huhtala, Heini and Abd El Fattah, Abeer I and Amr, Khalda and El Erian, Alaa Mohamad and Patrikoski, Mimmi and Miettinen, Susanna},
  title = {Immunomodulatory Functions of Adipose Mesenchymal Stromal/Stem Cell Derived From Donors With Type 2 Diabetes and Obesity on CD4 T Cells},
  journal = {Stem Cells},
  year = {2023},
  volume = {41},
  number = {5},
  pages = {505--519},
  doi = {10.1093/stmcls/sxad021}
}
Kostenlos starten →